Aerovate Therapeutics Inc (JBIO): Net Assets per Single Share
The market price of Aerovate Therapeutics Inc (JBIO), as confirmed by the chart, stands at 6.92. The business focuses on developing advanced inhalers to combat rare lung pathologies; however, the lack of stable cash flow and the need for investment render revenues unpredictable. Following trial failures, management optimized the workforce, retaining only key scientists to adjust the overall strategic direction.
Summary analytical data breakdowns for Aerovate Therapeutics, Inc. (JBIO)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Aerovate Therapeutics Inc|JBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Aerovate|JBIO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Aerovate Therapeutics|JBIO - Company Long-Term Liabilities|Company Short-Term Debts Aerovate Therapeutics Inc|Quick Liquidity Indicator aerovatetx.com
- earnings and multiples data:
General company analysis:JBIO - aerovatetx.com
As Aerovate Therapeutics Inc (JBIO) seeks a strategic buyer following clinical failures, the company is effectively shifting into a residual resource management mode. This metric measures the remaining equity per share, determining the intrinsic value of the business net of all debts, which allows investors to assess the company's liquid base through the dynamics of net assets per common share.
Competitor analysis
Argenx - Book Value per Share|Net Assets per Share BioNTech Pharma BNTX|Abivax Corp (ABVX) - Net Assets per Single Share|Net Asset Value per Share admabiologics.com (ADMA)|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma (VERA) - Net Assets per Single Share|Accounting Value per Share Dianthus Corp|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp|Accounting Value per Share TRML (Tourmaline Bio)|PGEN (Precigen Inc) - Accounting Value of a Share|Book Value per Share PHAR (Pharming)|Net Assets per Share Nektar Corp (NKTR)|UPB - Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|Immunome (IMNM) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|Accounting Value per Share KALV|Book Value per Share Septerna Pharma|Net Assets per Single Share Pieris Pharmaceuticals (PVLA)|savarapharma.com - Equity per Share|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|AnaptysBio Inc (ANAB) - Net Asset Value per Share|Astria Pharma - Book Value per Share|ENGN - Book Value per Share|RAPT: Book Value per Share|Net Asset Value per Share aclaristx.com (ACRS)|Net Assets per Single Share Kyverna Therapeutics, Inc.|TLSA: Accounting Value of a Share|Net Assets per Single Share Cabaletta Bio, Inc (CABA)|VTYX - Net Asset Value per Share|Theratechnologies Inc. - Accounting Value per Share|avalotx.com - Net Assets per Single Share|Eledon Pharmaceuticals, Inc. - Book Value per Share|AGEN - Book Value per Share|CLYM (Climb Bio, Inc.) - Accounting Value per Share|ZURA: Book Price of a Share|ATYR (aTyr Pharma, Inc.) - Book Value per Share|Net Asset Value per Share Adagene Corp ADAG|Accounting Value per Share IMA (ImageneBio Inc)|STTK (shattucklabs.com) - Accounting Value of a Share|Equillium - Accounting Value per Share|Book Price of a Share CNTB (Connect Biopharma Holdings)|Immunic Inc - Book Value per Share|Accounting Value of a Share ATRA (Atara Biotherapeutics)|IFRX: Book Value per Share|Net Asset Value per Share X4 Pharmaceuticals Inc. (XFOR)|Net Assets per Single Share Adicet Bio Inc.|CELU: Accounting Value of a Share|Book Value per Share INMB|Book Value per Share barinthusbio.com (BRNS)|Net Assets per Single Share Kezar Life Sciences, Inc. KZR|SABS (SAB Biotherapeutics Inc.) - Share Book Value|Akari Therapeutics plc - Book Value per Share|Net Asset Value per Share Enlivex Therapeutics|QTTB (q32bio.com) - Accounting Value per Share|geovax.com (GOVX) - Book Value per Share|Accounting Value per Share EDSA|IBIO (iBio Inc) - Book Price of a Share|Book Value per Share CARM|Net Assets per Share XTL Bio|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Accounting Value per Share|APVO - Net Assets per Single Share|Net Assets per Share AIM ImmunoTech, Inc. AIM|ADTX (aditxt.com) - Accounting Value per Share|GRI Bio Corporation - Accounting Value of a Share|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|reshapelifesciences.com (HIND) - Net Assets per Share|Net Assets per Single Share Revelation Biosciences, Inc. (REVB)|Indaptus Therapeutics Inc - Equity per Share|Book Value per Share SCNI (Scinai)|CALI - Accounting Value per Share|AFMD - Net Assets per Single Share|Allakos Inc. - Book Price of a Share|HOOK: Book Value per Share|IGMS (IGM Biosciences) - Net Assets per Single Share|ITOS (iTeos) - Book Value per Share|Ocean Biomedical Corp (OCEA) - Net Assets per Share|Net Assets per Single Share TC Biopharm (TCBP)|THRD - Net Asset Value per Share